| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 8.03e-05 | 3 | 104 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.06e-04 | 18 | 104 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | dATP binding | 2.66e-04 | 5 | 104 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 3.98e-04 | 6 | 104 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 5.55e-04 | 7 | 104 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 5.55e-04 | 31 | 104 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.74e-04 | 129 | 104 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 6.68e-04 | 33 | 104 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 9.44e-04 | 9 | 104 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.17e-03 | 151 | 104 | 5 | GO:0015085 | |
| GeneOntologyCellularComponent | nuclear pore inner ring | 7.76e-05 | 3 | 107 | 2 | GO:0044611 | |
| Domain | TPR_1 | 3.74e-08 | 90 | 104 | 8 | IPR001440 | |
| Domain | TPR_1 | 3.74e-08 | 90 | 104 | 8 | PF00515 | |
| Domain | TPR-contain_dom | 1.93e-06 | 150 | 104 | 8 | IPR013026 | |
| Domain | ARM-type_fold | NCAPD3 DNAJC13 AP3B1 RYR3 ITPR1 ITPR2 FOCAD VAC14 MROH2B NUP188 AGTPBP1 | 2.97e-06 | 339 | 104 | 11 | IPR016024 |
| Domain | RIH_assoc-dom | 3.31e-06 | 6 | 104 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 3.31e-06 | 6 | 104 | 3 | PF08709 | |
| Domain | RIH_assoc | 3.31e-06 | 6 | 104 | 3 | PF08454 | |
| Domain | RIH_dom | 3.31e-06 | 6 | 104 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.31e-06 | 6 | 104 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.31e-06 | 6 | 104 | 3 | IPR015925 | |
| Domain | - | 3.31e-06 | 6 | 104 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.31e-06 | 6 | 104 | 3 | PF01365 | |
| Domain | TPR_REGION | 3.93e-06 | 165 | 104 | 8 | PS50293 | |
| Domain | TPR | 3.93e-06 | 165 | 104 | 8 | PS50005 | |
| Domain | TPR-like_helical_dom | 6.16e-06 | 233 | 104 | 9 | IPR011990 | |
| Domain | TPR | 7.76e-06 | 129 | 104 | 7 | SM00028 | |
| Domain | MIR | 1.96e-05 | 10 | 104 | 3 | PF02815 | |
| Domain | MIR_motif | 1.96e-05 | 10 | 104 | 3 | IPR016093 | |
| Domain | MIR | 1.96e-05 | 10 | 104 | 3 | PS50919 | |
| Domain | MIR | 1.96e-05 | 10 | 104 | 3 | SM00472 | |
| Domain | InsP3_rcpt-bd | 9.18e-05 | 3 | 104 | 2 | IPR000493 | |
| Domain | SHR-BD | 1.83e-04 | 4 | 104 | 2 | IPR009543 | |
| Domain | VPS13_C | 1.83e-04 | 4 | 104 | 2 | PF16909 | |
| Domain | VPS13_C | 1.83e-04 | 4 | 104 | 2 | IPR031645 | |
| Domain | SHR-BD | 1.83e-04 | 4 | 104 | 2 | PF06650 | |
| Domain | Autophagy-rel_C | 3.04e-04 | 5 | 104 | 2 | IPR015412 | |
| Domain | ATG_C | 3.04e-04 | 5 | 104 | 2 | PF09333 | |
| Domain | LRR_8 | 3.90e-04 | 171 | 104 | 6 | PF13855 | |
| Domain | LRR_TYP | 4.69e-04 | 177 | 104 | 6 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 4.69e-04 | 177 | 104 | 6 | IPR003591 | |
| Domain | Chorein_N | 8.41e-04 | 8 | 104 | 2 | PF12624 | |
| Domain | Retinal_BS | 8.41e-04 | 8 | 104 | 2 | IPR027430 | |
| Domain | VPS13_N | 8.41e-04 | 8 | 104 | 2 | IPR026854 | |
| Domain | MAGE | 8.85e-04 | 34 | 104 | 3 | SM01373 | |
| Domain | TPR_repeat | 8.89e-04 | 133 | 104 | 5 | IPR019734 | |
| Domain | MAGE | 1.05e-03 | 36 | 104 | 3 | PS50838 | |
| Domain | MHD_dom | 1.05e-03 | 36 | 104 | 3 | IPR002190 | |
| Domain | MAGE | 1.05e-03 | 36 | 104 | 3 | PF01454 | |
| Domain | - | 1.06e-03 | 207 | 104 | 6 | 1.25.40.10 | |
| Domain | STI1 | 1.34e-03 | 10 | 104 | 2 | SM00727 | |
| Domain | OPSIN | 1.34e-03 | 10 | 104 | 2 | PS00238 | |
| Domain | STI1_HS-bd | 1.34e-03 | 10 | 104 | 2 | IPR006636 | |
| Domain | LRR_1 | 1.42e-03 | 219 | 104 | 6 | PF00560 | |
| Domain | - | 1.52e-03 | 222 | 104 | 6 | 1.25.10.10 | |
| Domain | Grip | 1.63e-03 | 11 | 104 | 2 | SM00755 | |
| Domain | GRIP | 1.63e-03 | 11 | 104 | 2 | PF01465 | |
| Domain | Opsin | 1.63e-03 | 11 | 104 | 2 | IPR001760 | |
| Domain | Ran_BP1 | 1.95e-03 | 12 | 104 | 2 | PF00638 | |
| Domain | RANBD1 | 1.95e-03 | 12 | 104 | 2 | PS50196 | |
| Domain | GRIP_dom | 1.95e-03 | 12 | 104 | 2 | IPR000237 | |
| Domain | GRIP | 1.95e-03 | 12 | 104 | 2 | PS50913 | |
| Domain | LRRNT | 2.19e-03 | 98 | 104 | 4 | IPR000372 | |
| Domain | LRRNT | 2.19e-03 | 98 | 104 | 4 | SM00013 | |
| Domain | RanBD | 2.30e-03 | 13 | 104 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 2.30e-03 | 13 | 104 | 2 | IPR000156 | |
| Domain | LRRNT | 3.21e-03 | 53 | 104 | 3 | PF01462 | |
| Domain | TPR_8 | 3.21e-03 | 53 | 104 | 3 | PF13181 | |
| Domain | ARM-like | 4.02e-03 | 270 | 104 | 6 | IPR011989 | |
| Domain | Leu-rich_rpt | 4.09e-03 | 271 | 104 | 6 | IPR001611 | |
| Domain | DH_1 | 5.23e-03 | 63 | 104 | 3 | PS00741 | |
| Domain | LRR | 5.34e-03 | 201 | 104 | 5 | PS51450 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.19e-06 | 73 | 74 | 6 | MM14948 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 8.50e-06 | 92 | 74 | 6 | MM14951 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 2.22e-05 | 11 | 74 | 3 | M27466 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.27e-04 | 19 | 74 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 2.69e-04 | 5 | 74 | 2 | M49000 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.94e-04 | 25 | 74 | 3 | MM14511 | |
| Pubmed | DCHS2 KALRN LRSAM1 CLIC6 DCN TRIM59 ST13 RYR3 FOCAD DIP2A PPP3CA HPF1 FBXO7 ROBO1 DHX35 AGTPBP1 DOP1B | 4.03e-07 | 1285 | 107 | 17 | 35914814 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VPS13C SLFN5 ZZEF1 CHRNB4 NUP205 ITPR2 FOCAD DIP2A ZBED4 NUP188 USP39 CNOT1 DOP1B | 4.49e-07 | 736 | 107 | 13 | 29676528 |
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 23463619 | ||
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 5.62e-07 | 6 | 107 | 3 | 25966694 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 5.62e-07 | 6 | 107 | 3 | 16844763 | |
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 9.82e-07 | 7 | 107 | 3 | 22495310 | |
| Pubmed | 4.83e-06 | 215 | 107 | 7 | 35973513 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 18708078 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15201137 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12719380 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 9.38e-06 | 2 | 107 | 2 | 23582047 | |
| Pubmed | Soluble adenylyl cyclase mediates hydrogen peroxide-induced changes in epithelial barrier function. | 9.38e-06 | 2 | 107 | 2 | 26857816 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 36420970 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 9.38e-06 | 2 | 107 | 2 | 19120126 | |
| Pubmed | St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis. | 9.38e-06 | 2 | 107 | 2 | 35562743 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TTF2 RGPD8 VPS13C VARS2 ZZEF1 ST13 ITPR1 ITPR2 DIP2A MTX3 SEC24B FBXO7 DHX35 NUP188 VPS13B KIF2C | 1.37e-05 | 1496 | 107 | 16 | 32877691 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.40e-05 | 497 | 107 | 9 | 36774506 | |
| Pubmed | 2.68e-05 | 504 | 107 | 9 | 34432599 | ||
| Pubmed | Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland. | 2.81e-05 | 3 | 107 | 2 | 21435446 | |
| Pubmed | Identification PMS1 and PMS2 as potential meiotic substrates of CDK2 activity. | 2.81e-05 | 3 | 107 | 2 | 36952545 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 10874040 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 9808793 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 20395455 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17437169 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 18194433 | ||
| Pubmed | Calcium-dependent interaction of calcineurin with Bcl-2 in neuronal tissue. | 2.81e-05 | 3 | 107 | 2 | 12617961 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 18547250 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 36350267 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 32320395 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 2.81e-05 | 3 | 107 | 2 | 27777977 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 11413485 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 2.81e-05 | 3 | 107 | 2 | 17581770 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 2.81e-05 | 3 | 107 | 2 | 18241669 | |
| Pubmed | Receptor-activated single channels in intact human platelets. | 2.81e-05 | 3 | 107 | 2 | 1693919 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 19068129 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 23955339 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 2.81e-05 | 3 | 107 | 2 | 24904548 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17327232 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 23223241 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 16014380 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 2.81e-05 | 3 | 107 | 2 | 23983250 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 2.81e-05 | 3 | 107 | 2 | 9858485 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 8521476 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 20427533 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 27653855 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KALRN MAPKAPK2 ZZEF1 PLEKHG5 ITPR2 FOCAD DIP2A VAC14 POMGNT2 ZBED4 NUP188 SNAPC4 GGA1 | 3.59e-05 | 1105 | 107 | 13 | 35748872 |
| Pubmed | Cul3-Klhl18 ubiquitin ligase modulates rod transducin translocation during light-dark adaptation. | 3.62e-05 | 21 | 107 | 3 | 31696965 | |
| Pubmed | FYTTD1 AVL9 SLITRK3 GCNT4 CUL5 SEMA3D FBXO7 HERC6 HYDIN VPS13B | 5.27e-05 | 686 | 107 | 10 | 29987050 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 25215520 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 28380328 | ||
| Pubmed | Expressions of rod and cone photoreceptor-like proteins in human epidermis. | 5.60e-05 | 4 | 107 | 2 | 19493002 | |
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 5.60e-05 | 4 | 107 | 2 | 21424589 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 15498460 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 21818117 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 2707487 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 25380047 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 28615414 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 10828023 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 5.60e-05 | 4 | 107 | 2 | 23413940 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 9607712 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 9480752 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 28419336 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 19120137 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 11163362 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 5.60e-05 | 4 | 107 | 2 | 35494252 | |
| Pubmed | Opsin3 Downregulation Induces Apoptosis of Human Epidermal Melanocytes via Mitochondrial Pathway. | 9.32e-05 | 5 | 107 | 2 | 31730232 | |
| Pubmed | Mesenchymal dysplasia: a recessive mutation on chromosome 13 of the mouse. | 9.32e-05 | 5 | 107 | 2 | 8830098 | |
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 9.32e-05 | 5 | 107 | 2 | 21568942 | |
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 26420485 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 12079276 | ||
| Pubmed | Spatiotemporal expression pattern of ceramide kinase-like in the mouse retina. | 9.32e-05 | 5 | 107 | 2 | 21151604 | |
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 11782428 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 11055434 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 19706527 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 24643499 | ||
| Pubmed | DNAJC13 IQGAP2 KALRN AP3B1 PLEKHG5 ST13 ITPR2 CUL5 DIP2A PPP3CA WASHC5 ST13P5 CNOT1 AGTPBP1 | 1.27e-04 | 1431 | 107 | 14 | 37142655 | |
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 1.40e-04 | 6 | 107 | 2 | 21762810 | |
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 8530061 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 35679425 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 36807146 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 17436273 | ||
| Pubmed | Retinal remodeling triggered by photoreceptor degenerations. | 1.40e-04 | 6 | 107 | 2 | 12866125 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TTF2 NCAPD3 AP3B1 NUP205 VAC14 TIMM21 LPCAT2 MTX3 SEC24B NUP188 CDK2 | 1.58e-04 | 942 | 107 | 11 | 31073040 |
| Pubmed | 1.86e-04 | 650 | 107 | 9 | 38777146 | ||
| Pubmed | BBS mutations modify phenotypic expression of CEP290-related ciliopathies. | 1.95e-04 | 7 | 107 | 2 | 23943788 | |
| Pubmed | The CRL5-SPSB3 ubiquitin ligase targets nuclear cGAS for degradation. | 1.95e-04 | 7 | 107 | 2 | 38418882 | |
| Pubmed | Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome. | 1.95e-04 | 7 | 107 | 2 | 26878725 | |
| Pubmed | Retarded developmental expression and patterning of retinal cone opsins in hypothyroid mice. | 1.95e-04 | 7 | 107 | 2 | 18974269 | |
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 31628458 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.95e-04 | 7 | 107 | 2 | 15710750 | |
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 19332056 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.21e-04 | 38 | 107 | 3 | 30786075 | |
| Pubmed | 2.37e-04 | 529 | 107 | 8 | 14621295 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 2.59e-04 | 8 | 107 | 2 | 19033399 | |
| Pubmed | 2.59e-04 | 8 | 107 | 2 | 21813673 | ||
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.47e-06 | 115 | 70 | 6 | 769 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 4.42e-05 | 3 | 70 | 2 | 297 | |
| GeneFamily | MAGE family | 4.96e-04 | 40 | 70 | 3 | 1136 | |
| GeneFamily | Opsin receptors | 7.95e-04 | 11 | 70 | 2 | 215 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 9.51e-04 | 12 | 70 | 2 | 573 | |
| GeneFamily | EF-hand domain containing | 1.59e-03 | 219 | 70 | 5 | 863 | |
| Coexpression | HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | VPS13C CGAS GCH1 SLFN5 IFIT2 KIF24 NUP205 LPCAT2 HERC6 CMAHP | 4.65e-06 | 394 | 106 | 10 | M40996 |
| Coexpression | GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN | 1.64e-05 | 198 | 106 | 7 | M3302 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | 1.75e-05 | 200 | 106 | 7 | M8554 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 1.75e-05 | 200 | 106 | 7 | M7324 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-09 | 170 | 105 | 8 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-07 | 163 | 105 | 7 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.98e-07 | 186 | 105 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.83e-07 | 193 | 105 | 7 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.71e-06 | 153 | 105 | 6 | 859de35b24c5d7d73be1c213b90b43362ee2e0eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 159 | 105 | 6 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-06 | 177 | 105 | 6 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.66e-06 | 182 | 105 | 6 | e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.12e-06 | 185 | 105 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-06 | 191 | 105 | 6 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 6.52e-06 | 193 | 105 | 6 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.92e-06 | 195 | 105 | 6 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | IIH-CD4-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 2.67e-05 | 148 | 105 | 5 | ec626a44cea83f2a0e5c27fc8182f96446d297ac | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.75e-05 | 149 | 105 | 5 | a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.43e-05 | 156 | 105 | 5 | 7ccd20e3bbce6a070df45034b0bdc255f267efb1 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.99e-05 | 161 | 105 | 5 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.46e-05 | 172 | 105 | 5 | ba36581ae339191a12a6d3ead39eaf69d78be10e | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-05 | 173 | 105 | 5 | 0451450605521fecb27a958628870d268adfb023 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.26e-05 | 177 | 105 | 5 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 178 | 105 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-05 | 179 | 105 | 5 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.95e-05 | 181 | 105 | 5 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.71e-05 | 185 | 105 | 5 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.91e-05 | 186 | 105 | 5 | fc0b488c201a32d829047b58460297df2818b45d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-05 | 187 | 105 | 5 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.11e-05 | 187 | 105 | 5 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-05 | 187 | 105 | 5 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 8.32e-05 | 188 | 105 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 188 | 105 | 5 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.53e-05 | 189 | 105 | 5 | 99b01893da9f9f7c9528afaffad178285211738b | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.53e-05 | 189 | 105 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.96e-05 | 191 | 105 | 5 | b2759c1ce3793a0913d49b91576a9ab641dfea8f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 191 | 105 | 5 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 191 | 105 | 5 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 9.18e-05 | 192 | 105 | 5 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 9.18e-05 | 192 | 105 | 5 | b0a573ddde2978485a857b8261ee1ee5ef68ecef | |
| ToppCell | BAL-Mild|BAL / Compartment, Disease Groups and Clusters | 9.18e-05 | 192 | 105 | 5 | 1a6cbf014d3f7a3fb6f53adab078c4742e7137de | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 105 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 105 | 5 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.04e-04 | 197 | 105 | 5 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 198 | 105 | 5 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-04 | 199 | 105 | 5 | d3f77acb36ac7c56a47ca98b695f46ae5b9ecd12 | |
| ToppCell | distal-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-04 | 199 | 105 | 5 | b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.09e-04 | 199 | 105 | 5 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.11e-04 | 200 | 105 | 5 | 501cd2b4e55444fc5fdd93ebbcfc0616442b110b | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.11e-04 | 200 | 105 | 5 | 2086024ce808b8796ed508a229b098eb02f8828a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.11e-04 | 200 | 105 | 5 | 35951db6a4f442ac9e13f1b8cc5b4a33481f92c8 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-DCs|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.11e-04 | 200 | 105 | 5 | e0beacb88bbdc353a3e883171613027feafcf1ef | |
| Disease | Anoxic Encephalopathy | 1.16e-05 | 2 | 101 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 1.16e-05 | 2 | 101 | 2 | C1527348 | |
| Disease | Anoxia of brain | 1.16e-05 | 2 | 101 | 2 | C0995195 | |
| Disease | Hypoxic Brain Damage | 1.16e-05 | 2 | 101 | 2 | C1140716 | |
| Disease | polymyositis (is_implicated_in) | 3.47e-05 | 3 | 101 | 2 | DOID:0080745 (is_implicated_in) | |
| Disease | dermatomyositis (is_implicated_in) | 3.47e-05 | 3 | 101 | 2 | DOID:10223 (is_implicated_in) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 3.47e-05 | 3 | 101 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | PPP1R21 DNAJC13 IQGAP2 KALRN LRSAM1 CASP10 GCH1 ITPR2 FOCAD BBS7 FBXO7 CMAHP VPS13B | 1.02e-04 | 1105 | 101 | 13 | EFO_0004528 |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 2.41e-04 | 7 | 101 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 7.49e-04 | 12 | 101 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Influenza | 7.62e-04 | 52 | 101 | 3 | C0021400 | |
| Disease | Rolandic epilepsy | 1.35e-03 | 16 | 101 | 2 | Orphanet_1945 | |
| Disease | response to phenylephrine | 1.53e-03 | 17 | 101 | 2 | EFO_0010152 | |
| Disease | Liver carcinoma | 1.82e-03 | 507 | 101 | 7 | C2239176 | |
| Disease | thrombin activatable fibrinolysis inhibitor activation peptide measurement | 1.91e-03 | 19 | 101 | 2 | EFO_0008582 | |
| Disease | response to ziprasidone | 2.12e-03 | 20 | 101 | 2 | GO_0097337 | |
| Disease | rheumatoid arthritis, ulcerative colitis | 2.33e-03 | 21 | 101 | 2 | EFO_0000685, EFO_0000729 | |
| Disease | red blood cell density measurement | 3.25e-03 | 880 | 101 | 9 | EFO_0007978 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FIIKRKPLFYTINLI | 226 | P30926 | |
| LKLIHPKLEYQLLLA | 606 | Q8IWZ6 | |
| LYNQPDCLKLLLKGR | 631 | Q8TDY4 | |
| SLVAFPKLKRQVLLY | 636 | Q93034 | |
| LPRLQKLYLDRNLIA | 241 | P35858 | |
| LNLKKSPVLQYLFFL | 596 | P23109 | |
| KALKLLNRIFPYNLI | 1156 | Q96PN6 | |
| LLKALRKLDNYLNSP | 596 | Q96NY7 | |
| AKGLLQYLAAVKRLP | 996 | Q9UPW5 | |
| AKVRKQLRLKPFYLV | 346 | Q8N884 | |
| LVKLQILNLGAKLYL | 531 | O00203 | |
| IKLNPRLAILYAKRA | 141 | Q8NFI4 | |
| IKLNPRLAILYAKRA | 141 | P50502 | |
| YLKNVLLQFIFLKPG | 1711 | Q99666 | |
| YLKNVLLQFIFLKPG | 1711 | O14715 | |
| KKLRTPLNYILLNLA | 66 | P08100 | |
| YLTVNKRLPALLEKN | 131 | Q14571 | |
| QLLPLAYNLLKRNLF | 311 | Q9NWY4 | |
| NLALYLLGFELKKPV | 1001 | Q92621 | |
| LLNPLIYSLRNKDVK | 286 | Q8NGK9 | |
| LPQLKSYLRQKLQAL | 526 | Q14296 | |
| LAPLYKVRFPKVQLQ | 206 | Q5HYI7 | |
| LYLANNKLTLAPRFL | 151 | Q7Z5L7 | |
| LVQFLLNKYIRKEPI | 116 | A8MXT2 | |
| ARFLLLKYQVKQPIT | 916 | O60732 | |
| LVQFLLLKYQAKEPL | 191 | Q8TD91 | |
| NLLYTSKRPNAILKL | 191 | P49137 | |
| GQLLPLAYNLLKRNL | 311 | A8MVJ9 | |
| LKKQCLQQLLFLYPE | 191 | Q8IV33 | |
| YLTVNKRLPALLEKN | 131 | Q14643 | |
| QYQRLLNQKPLSLKL | 551 | Q6UWE0 | |
| KYFLPLQKLLLPSLQ | 131 | Q9Y3R5 | |
| LERLYLSKNQLKELP | 131 | P07585 | |
| LPKLNNLYLRLQELV | 376 | Q8TDF6 | |
| NLPFPLALYKKLLDQ | 776 | Q8IVU3 | |
| LIKPIQRITKYQLLL | 2056 | O60229 | |
| PKTLIARRYVLQQKL | 21 | Q8NG66 | |
| LLQQKLKYQPLKRSL | 776 | Q5T7B8 | |
| LLLANPQKEKVRLRY | 596 | Q9UJY5 | |
| YKLLSPKQPLLRAQL | 206 | Q8NAT1 | |
| CFLRKILPYQLKSLE | 351 | Q6ZMI0 | |
| INPYLKLVLFQNKLH | 521 | Q8NFY9 | |
| YRLLLPRIKNKSKLQ | 956 | Q8TCU5 | |
| LKNEAYIPKLLQLFH | 166 | Q6ZMV5 | |
| YLIRALPLIKSQLNK | 2936 | Q6V1P9 | |
| KYLKLPVSDVLRQLF | 386 | Q7L5N7 | |
| ILRKFHYLLNPKQVF | 451 | P49619 | |
| NQYGNPLLLFKRLLL | 3486 | Q4G0P3 | |
| LLNVRRLFPQKDIYL | 31 | Q9P109 | |
| ARKQLVPLLYKQFVP | 36 | O43323 | |
| LQKLSRLFKDQLVYP | 301 | Q9Y3I1 | |
| VLKSLRYLVPLQSKN | 191 | Q6P4F1 | |
| RQKLPVFKLRNHILY | 51 | Q9H5Z1 | |
| LSKLPLYGLLQAKLQ | 121 | Q8NBF6 | |
| AQALKADLVPYLLKL | 2126 | O75165 | |
| NPLAFKPLKSLAYLR | 456 | O94769 | |
| LAYLRLGKNKFRIIP | 466 | O94769 | |
| PDNQYLKVLLALKLH | 206 | P09913 | |
| FQPKLAAYRQLPVLK | 416 | Q5VTH9 | |
| PFFLAELLYIIRQKK | 76 | Q92851 | |
| KRAKLLARYIPLIQG | 41 | Q14689 | |
| LPLIKSYLFQLLQGL | 101 | P24941 | |
| YKRKVLPLRLQNRLF | 41 | A4D161 | |
| LQKVCYLPLNTFLLK | 666 | O94887 | |
| LKLFPLYVLALLKQK | 1071 | O95487 | |
| VFLLKNQPCYRKLGL | 381 | Q99661 | |
| LRLFKNLPVRKQFYS | 146 | P54277 | |
| LKILYPKTLFLLRGN | 136 | Q08209 | |
| YAKLRLALLKVLLQP | 191 | Q5VW36 | |
| LVATLRYKKLRQPLN | 56 | P03999 | |
| LPLLAARRYKLQKQL | 996 | Q5ST30 | |
| RLQLLDVKNNPYLIK | 681 | Q08AM6 | |
| AIKLNPRLAILYAKR | 136 | Q8IZP2 | |
| FPRQYFALRKILKQL | 321 | Q9HCM9 | |
| LILKLRYFTPKEIAN | 336 | O14717 | |
| NFLKRFQLTKLPPYL | 436 | Q53GS9 | |
| KNREKYLLPFLSLQI | 86 | Q13571 | |
| LLQTNPLYLAKLIFQ | 891 | Q13576 | |
| YLPNKQVLGLSKLAR | 156 | P30793 | |
| RPLNAKKLYLSSNLI | 406 | O94933 | |
| LLLYPAKRKQLLRSE | 296 | Q8NHU6 | |
| ALIAIRYLSKLKPQL | 806 | Q7Z745 | |
| NIPRLKLTYKDLLLS | 41 | O95025 | |
| FERYLLSQKPKCLLQ | 396 | O15204 | |
| LNYKARLVKNLQPRI | 236 | Q9Y471 | |
| IFHLLKNFLRLLPKF | 216 | P42695 | |
| PNNILKLRNLDLLIY | 86 | Q8N326 | |
| QLLIDLFKYLAPFLR | 2066 | A5YKK6 | |
| EQYFPVLKRKANLLR | 131 | Q96QD9 | |
| QRLTKYPLLLKSVLR | 486 | O94827 | |
| NLPSYFRLQKPLLIL | 621 | Q9P2K2 | |
| FLIAQLPKLQYNKNL | 1046 | Q12768 | |
| LKNKRNPRLVPYALL | 1011 | Q15413 | |
| TVKLRLLIKLPELNY | 341 | Q14765 | |
| QILPTIYKRKNLSLF | 211 | Q8N394 | |
| QLLKTLRYNFLPEAL | 1406 | Q5SRE5 | |
| KRQRLPLALQNLFLY | 211 | Q96G79 | |
| LLARILQKNYPYIAK | 256 | Q9UH36 | |
| KVLDLRINLKPSYLV | 686 | Q709C8 | |
| IKGLKPNAIYLFLVR | 621 | Q9Y6N7 | |
| KRLLLPYIVLNKACL | 21 | Q9BVV7 | |
| RYIKNLKPSDLQLSL | 16 | Q7Z7G8 | |
| VRQNLLLKYGKPLQL | 516 | O43149 | |
| LQRLLQPKLLKLEYL | 201 | Q5SXM2 | |
| PILNRLAKIFYFLGK | 296 | Q5TAA0 | |
| FDRKRLQYLEKLNLP | 176 | Q08AF3 | |
| YRQPLNVYCLLDKKL | 101 | Q8IWR1 | |
| QGLLLPQDKKEYRLF | 61 | Q9UNY4 | |
| KLIFLKVNLPLIYFQ | 1156 | O75132 |